La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Edwards Lifesciences Gestione
Gestione criteri di controllo 3/4
Edwards Lifesciences' Il CEO è Bernard Zovighian, nominato in May2023, e ha un mandato di 1.25 anni. la retribuzione annua totale è $ 12.87M, composta da 7.6% di stipendio e 92.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.012% delle azioni della società, per un valore di $ 4.93M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 4.9 anni e 4.3 anni.
Informazioni chiave
Bernard Zovighian
Amministratore delegato
US$12.9m
Compenso totale
| Percentuale dello stipendio del CEO | 7.6% |
| Mandato del CEO | 1.3yrs |
| Proprietà del CEO | 0.01% |
| Durata media del management | 5yrs |
| Durata media del Consiglio di amministrazione | 4.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Bearish: Analysts Just Cut Their Edwards Lifesciences Corporation (NYSE:EW) Revenue and EPS estimates
Sep 11
Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$13m | US$973k | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$3m | US$642k | US$2b |
Compensazione vs Mercato: La retribuzione totale di Bernard ($USD 12.87M ) è circa la media per le aziende di dimensioni simili nel mercato US ($USD 13.21M ).
Compensazione vs guadagni: La retribuzione di Bernard è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Bernard Zovighian (56 yo)
1.3yrs
Mandato
US$12,869,020
Compensazione
Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 1.3yrs | US$12.87m | 0.012% $ 4.8m | |
| Corporate VP & CFO | 10.7yrs | US$5.95m | 0.045% $ 18.2m | |
| Corporate Vice President of Strategy & Corporate Development | 8.6yrs | US$4.29m | 0.034% $ 13.7m | |
| Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.7yrs | US$5.40m | 0.034% $ 13.6m | |
| Principal Accounting Officer | less than a year | Nessun dato | 0.00029% $ 116.3k | |
| Corporate VP of Advanced Technology & Chief Scientific Officer | 5.6yrs | Nessun dato | Nessun dato | |
| Vice President of Investor Relations | no data | Nessun dato | Nessun dato | |
| Corporate VP & General Counsel | 5yrs | Nessun dato | Nessun dato | |
| Corporate Vice President of Public Affairs | 11.3yrs | Nessun dato | Nessun dato | |
| Corporate Vice President of Human Resources | 12.1yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Quality & Regulatory Compliance | 1.2yrs | Nessun dato | Nessun dato | |
| GM & Senior VP of Surgical Structural Heart | 1.1yrs | Nessun dato | 0.00021% $ 84.2k |
5.0yrs
Durata media
58yo
Età media
Gestione esperta: Il team dirigenziale di EW è esperto e expertise (durata media dell'incarico 5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO & Director | 1.3yrs | US$12.87m | 0.012% $ 4.8m | |
| Independent Director | 9.6yrs | US$335.06k | 0.012% $ 4.8m | |
| Independent Director | 4.2yrs | US$329.97k | 0.0013% $ 513.4k | |
| Independent Director | 8.5yrs | US$335.06k | 0.012% $ 4.7m | |
| Independent Director | 8.2yrs | US$356.42k | 0.0045% $ 1.8m | |
| Independent Chairman | 9.8yrs | US$347.97k | 0.011% $ 4.6m | |
| Independent Director | less than a year | Nessun dato | Nessun dato | |
| Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 4.3yrs | US$334.97k | 0.0018% $ 734.0k |
4.3yrs
Durata media
64yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di EW sono considerati esperti (durata media dell'incarico 4.3 anni).